Audit of fiducial marker placement and utility in image

Slides:



Advertisements
Similar presentations
METHODOLOGY FOR META- ANALYSIS OF TIME TO EVENT TYPE OUTCOMES TO INFORM ECONOMIC EVALUATIONS Nicola Cooper, Alex Sutton, Keith Abrams Department of Health.
Advertisements

In the past few years the usage of conformal and IMRT treatments has been increasing rapidly. These treatments employ the use of tighter margins around.
National Prostate Cancer Audit: Review of the Organisational Audit Dr Ajay Aggarwal Oncology Coordinator NPCA Honorary.
Models for breathing trajectory variations Gregory C. Sharp Massachusetts General Hospital Feb 19, 2010 MASSACHUSETTS GENERAL HOSPITAL RADIATION ONCOLOGY.
The School of Dentistry College of Medical & Dental Sciences 'Evaluation of Single-unit Light-cured Composite Temporary Crowns in General Practice' R.J.CRISP.
IGRT Prostate – the ADHB experience Nicola Gordon Imaging Specialist RT ADHB.
Image Guided Radiation Therapy (IGRT) in prostate cancer MªCarmen Pujades Hospital Universitario La Fe Fundación Instituto Valenciano de Oncología (FIVO)
An Audit of breast radiotherapy reproducibility and an assessment of the role of breast volume on field placement accuracy. Heidi Probst PhD, Sarah Hielscher.
Introduction Our vision is to provide the cancer patient with cutting edge technology that improves patient care and increases research opportunities With.
Perma Permanent Brachytherapy Medical Events: Experiences of Pennsylvania Frank Costello Organization of Agreement States August 28, 2012 Milwaukee, Wisconsin.
Radiotherapy - the art of the invisible Terry Kehoe Consultant Clinical Scientist Head of Oncology Physics Edinburgh Cancer Centre “How to crack a walnut”
Comparison of Rectal Dose Volume Histograms for Definitive Prostate Radiotherapy Among Stereotactic Radiotherapy, IMRT, and 3D-CRT Techniques Author(s):
H Ariyaratne1,2, H Chesham2, J Pettingell2, K Sikora2, R Alonzi1,2
PSA Shared Care Jim Wood. Background A significant number of men with prostate cancer (CaP) are receiving regular hospital follow up (out- patient visits),
Intra and Inter-Therapist Reproducibility of Daily Isocenter Verification Using Prostatic Fiducial Markers Holly Ning, Karen L. Ullman, Robert W. Miller,
12/09/2011Position Sensitive Detectors 91 &. 12/09/2011Position Sensitive Detectors 92 Tracking of Moving Fiducial Markers during Radiotherapy using a.
Endometrial Cancer CPGON Audit. Background Formulating standard management pathways Assessing compliance with existing pathways Understanding areas of.
Assessment of radiotherapy set-up error for limb sarcoma using electronic portal imaging (EPI) Wendy Ella, Eleanor Gill, Anna Cassoni, Beatrice Seddon.
Assessing the benefits of a stratified treatment strategy which improves average HbA1c in a proportion of patients with Type 2 diabetes: a MASTERMIND study.
Peripatetic Prostates and Fiducial Markers – a Simple Solution to a Complex Problem? Jo Treeby Radiographer Advanced Practitioner Urology Addenbrooke’s.
Does my bum look big in this? Audit of rectal volumes and AP diameter in planning scans for radical prostate radiotherapy Tse V, Lorimer CFK, Parker R,
RECTAL CARCINOMA AND PREOPERATIVE MRI: USING A NATIONAL DATASET FOR REGIONAL AUDIT South West Cancer Intelligence Service J Weeks
Ο ρόλος των μη χειρουργικών θεραπειών στο μη μεταστατικό μυοδιηθητικό καρκίνο ουροδόχου κύστεως Γεώργιος Δ. Λύπας Παθολόγος Ογκολόγος Α’ Ογκολογική Κλινική.
Prostate cancer and socio-economic deprivation When PCTs are ranked according to their income score using the Indices of Multiple Deprivation (IMD)* there.
References : [1] Hurkmans CW, et al Set-up verification using portal imaging; review of current clinical practice. Radiother. Oncol. 2001;58: [2]
A comparison between soft tissue and bone registration techniques for prostate radiotherapy Richard Small, Paul Bartley, Audrey Ogilvie, Nick West and.
SURGEON-PERFORMED ULTRASOUND FOR STENT POSITION IN LAPAROSCOPIC PYELOPLASTY Stephen D Adams, Costa Healy, Sengamalai Manoharan, Stephen Griffin, Henrik.
Measures Functional Assessment of Cancer Therapy: Prostate (FACT-P). The FACT-P (Cella et al., 1993; Esper et al., 1997) is a widely-used self-report measure(e.g.,
Dr. Malhar Patel DNB (Radiation Oncology)
Goals & Roll Out Urinary catheter care bundles
DESIGN AND APPROVAL OF A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED TRIAL OF THE ACE INHIBITOR CAPTOPRIL IN COMBINATION WITH IBUPROFEN IN THE TREATMENT.
By: Matthew Kosch Advantages and Recent Implementation of Fiducials in Image-Guided Radiation Therapy.
When Using DOPPS Slides
Oesophageal brachytherapy
Tips for Inserting Graphs or Images Tips for Title/Headers Bar Color
Greg Rubin,1 Nafees Din,2 Richard Neal,2 William Hamilton3
San Antonio Breast Cancer Symposium - December 6-10, 2011 Pre-operative haematological markers and prognosis in early breast cancer Cordiner RL1, Mansell.
Author #1a and Author #2b (28-32 pt. Arial Bold)
Stage I Non Small Cell Lung Cancer (NSCLC): single centre comparison of outcome by treatment with surgery, conventional radiotherapy and stereotactic ablative.
Introduction Our vision is to provide the cancer patient with cutting edge technology that improves patient care and increases research opportunities With.
The ART of Decision Making : Retreatment with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Wolfgang Sieghart, Florian Hucke,
Treatment allocation bias
The use of 4DCT images to optimize the Internal Target Volume in Radiotherapy  Nikos Giakoumakis, Brian Winey, Joseph Killoran, Tania Lingos, Laurence.
Feasibility of hippocampal sparing radiation therapy for glioblastoma using helical Tomotherapy Dr Kamalram THIPPU JAYAPRAKASH1,2,3, Dr Raj JENA1,4 and.
Impact of State Reporting Laws on Central Line– Associated Bloodstream Infection Rates in U.S. Adult Intensive Care Units Hangsheng Liu, Carolyn T. A.
Introduction and Objectives
#96 Roles Of Urodynamics In the Assessment of Post Radical
Urologist’s Impact on Extended Needle Core Prostate Biopsy Histopathologic Variables within a Single Institution Kashika G. Goyal B.S.1, Joshua J. Ebel.
Comparison of carina- versus bony anatomy-based registration for setup verification in esophageal cancer image-guided radiotherapy Melanie Machiels* 1,
hospitalized with spontaneous bacterial peritonitis
Figure 1. The (a) anterior–posterior and (b) right-lateral fields and (c, d) the isodose distributions of two axial planes in one patient with T2 stage.
Introduction to CAUTI and CLABSI Initiatives
CONTACT Catalina A. Riley
Karla Leach, BS, CMD Texas Center for Proton Therapy-Irving, TX
Pediatric Central Venous Catheters In Patients Less Than Two Years Of Age: Do Complication Rates Differ Between Tunneled IJ, Tunneled Femoral, and PICCs?
The BAHNO Head & Neck Cancer Surveillance Audit 2018
Insert tables Insert graphs Insert figure
The BAHNO Head & Neck Cancer Surveillance Audit 2018
The Development of an Innovative Nurse-Led Ovarian Cancer Survivorship Clinic Sarah Burton Macmillan Clinical nurse specialist, Clare Churcher Clinical.
The Development of an Innovative Nurse-Led Ovarian Cancer Survivorship Clinic Sarah Burton Macmillan Clinical nurse specialist, Clare Churcher Clinical.
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
The BAHNO Head & Neck Cancer Surveillance Audit 2018
Background Methods Results Conclusion References cited
Practical Assessment of Bronchoscopically Inserted Fiducial Markers for Image Guidance in Stereotactic Lung Radiotherapy  Price Jackson, PhD, Daniel P.
Efficacy of fiducial marker-based image-guided radiation therapy in prostate tomotherapy and potential dose coverage improvement using a patient positioning.
A single centre experience of febrile neutropenia rates in long acting compared with short acting GCSF preparations in breast cancer patients Dr Rebecca.
THE LANCET Oncology Volume 19, No. 1, p27–39, January 2018
Making it Easy: Health Literacy Outcomes to improve social care
The Scientific Method.
Presentation transcript:

Audit of fiducial marker placement and utility in image guided prostate radiotherapy IS Bhattacharya, R Hughes Mount Vernon Cancer Centre, Northwood, United Kingdom Background Fiducial markers are inserted prior to radiotherapy to allow image guided treatment. 3 single markers are inserted except for trial patients where 2 paired markers are used within our centre. There are no guidelines on the optimum separation between markers and what the acceptable proportion of usable markers is. The aim is to identify what proportion of markers are usable, compare single and double markers and measure the shifts performed. Methods Demographic data, usability of markers, shortest distances between markers and shifts applied was collected on markers inserted between January and September 2013. Results 113 patients had single markers inserted; these were not used in 13 patients. 7 patients had double markers inserted and all were used. In the 13 patients where markers were not used; 2 had changes of radiotherapy plan and 1 required CBCT to assess bladder filling. Markers were unusable in 10/13 patients; 4 had only 2 visible markers, 5 had inappropriately positioned markers either too closely related or positioned outside the gland and 1 the markers moved during treatment. Table 1: Average distances between single markers on D1 and D19   AP distance1 AP distance 2 PA distance 1 PA distance2 DAY1 1.16(0.22-3.41) 2.14(0.63-3.62) 0.98(0.22-2.42) 1.49(0.34-2.96) DAY 19 1.15(0.33-3.22) 2.13(0.08-4.02) 0.93(0.22-2.44) 1.43(0.35-2.93) Table 2: Average distances between paired markers on D1 and D39   AP distance 1 AP distance 2 PA distance 1 PA distance 2 DAY 1 2.35(1.77-3.1) 2.75(2.38-3.51) 0.82(0.82-1.35) 0.96(0.69-1.65) DAY 39 2.25(1.77-2.96) 2.71(2.34-3.44) 0.71(0.56-1.28) 0.98(0.63-1.6) Table 3: Shifts applied using single and double fiducial markers (cm)   Average AP shift AP shift >0.5cm (n) Average S/I shift S/I shift >1cm (n) Average R/l shift R/L shift >1cm (n) DAY 1 Single markers 0.37 (0-1.58) 21 0.26 (0-1.69) 1 (0-1.01) DAY 19 0.39 (0-1.33) 19 0.33 3 0.25 (0-0.8) Double markers 0.56 (0.1-2.28) 2 0.6 (0-2.63) 0.32 (0.1-0.64) DAY 39 (0.09-0.7) 0.24 (0.09-0.34) 0.23 (0-0.5) Conclusion 10/113 (8.8%) were markers not used. Both types of marker allowed image guided radiotherapy however paired markers were more evenly distributed in the gland and maybe more representative of prostate position. The majority of shifts applied were in anterior/posterior direction. This audit established a baseline of marker usability and implant technique. A switch to paired markers for all patients may allow better prediction of prostate motion and fewer unusable markers. Reductions in shifts may potentially allow us to reduce our margins. For further information please contact: indrani.bhattacharya@nhs.net